Cizzle Biotechnology Holdings PLC

LSE:CIZ UK Biotechnology
Market Cap
$72.34K
GBX594.59 Million GBX
Market Cap Rank
#48468 Global
#1191 in UK
Share Price
GBX1.50
Change (1 day)
-3.23%
52-Week Range
GBX1.29 - GBX2.35
All Time High
GBX1144.91
About

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings … Read more

Cizzle Biotechnology Holdings PLC - Asset Resilience Ratio

Latest as of December 2023: 83.46%

Cizzle Biotechnology Holdings PLC (CIZ) has an Asset Resilience Ratio of 83.46% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
GBX1.41 Million
Cash + Short-term Investments
Total Assets
GBX1.69 Million
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2023–2023)

This chart shows how Cizzle Biotechnology Holdings PLC's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Cizzle Biotechnology Holdings PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX1.41 Million 83.46%
Total Liquid Assets GBX1.41 Million 83.46%

Asset Resilience Insights

  • Very High Liquidity: Cizzle Biotechnology Holdings PLC maintains exceptional liquid asset reserves at 83.46% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Cizzle Biotechnology Holdings PLC Industry Peers by Asset Resilience Ratio

Compare Cizzle Biotechnology Holdings PLC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Cizzle Biotechnology Holdings PLC (2023–2023)

The table below shows the annual Asset Resilience Ratio data for Cizzle Biotechnology Holdings PLC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 83.46% GBX1.41 Million GBX1.69 Million --
pp = percentage points